CTLA4 and breast neoplasm: The concept of using external radiation to sensitize poorly immunogenic tumors and enable immune response to CTLA-4 blockade has been demonstrated previously in a 4T1 breast tumor model and in several other preclinical and clinical studies [7, 15, 16].